SE0300456D0 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
SE0300456D0
SE0300456D0 SE0300456A SE0300456A SE0300456D0 SE 0300456 D0 SE0300456 D0 SE 0300456D0 SE 0300456 A SE0300456 A SE 0300456A SE 0300456 A SE0300456 A SE 0300456A SE 0300456 D0 SE0300456 D0 SE 0300456D0
Authority
SE
Sweden
Prior art keywords
novel compounds
variables
therapy
modulation
processes
Prior art date
Application number
SE0300456A
Other languages
Swedish (sv)
Inventor
Auten Pimm
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Priority to SE0300456A priority Critical patent/SE0300456D0/en
Publication of SE0300456D0 publication Critical patent/SE0300456D0/en
Priority to PCT/SE2004/000216 priority patent/WO2004074278A1/en

Links

Abstract

The invention relates to pyridine derivatives of formula (I) where the variables are defined in the specification.Processes for the preparation of these compounds together with pharmaceutical compositions containing them and their use in therapy in particular in the modulation of autoimmune disease is also described.
SE0300456A 2003-02-19 2003-02-19 Novel compounds SE0300456D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
SE0300456A SE0300456D0 (en) 2003-02-19 2003-02-19 Novel compounds
PCT/SE2004/000216 WO2004074278A1 (en) 2003-02-19 2004-02-18 Novel compounds

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0300456A SE0300456D0 (en) 2003-02-19 2003-02-19 Novel compounds

Publications (1)

Publication Number Publication Date
SE0300456D0 true SE0300456D0 (en) 2003-02-19

Family

ID=20290456

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0300456A SE0300456D0 (en) 2003-02-19 2003-02-19 Novel compounds

Country Status (2)

Country Link
SE (1) SE0300456D0 (en)
WO (1) WO2004074278A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007009945A (en) 2005-02-16 2007-09-26 Schering Corp Heterocyclic substituted piperazines with cxcr3 antagonist activity.
AU2006214480A1 (en) 2005-02-16 2006-08-24 Pharmacopeia, Inc. Novel heterocyclic substituted pyridine or phenyl compounds with CXCR3 antagonist activity
PE20071144A1 (en) 2006-03-21 2008-01-10 Schering Corp HETEROCYCLIC COMPOUNDS OF PYRIDINE SUBSTITUTED AS ANTAGONISTS OF α-CHEMOKIN RECEPTOR 3 (CXCR3)
WO2008008453A1 (en) 2006-07-14 2008-01-17 Schering Corporation Heterocyclic substituted piperazine compounds with cxcr3 antagonist activity
WO2008063888A2 (en) 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
US8093246B2 (en) * 2006-12-14 2012-01-10 Lexicon Pharmaceuticals, Inc. O-linked pyrimidin-4-amine-based compounds, compositions comprising them, and methods of their use to treat cancer
EP2141994A4 (en) * 2007-04-26 2011-05-18 Avalon Pharmaceuticals Multi-ring compounds and uses thereof
DE102008035552A1 (en) * 2008-07-30 2010-02-04 Bayer Schering Pharma Aktiengesellschaft Substituted pyridines and their use
MX349923B (en) 2009-04-03 2017-08-21 Hoffmann La Roche Propane- i-sulfonic acid {3- [5- (4 -chloro-phenyl) -1h-pyrrolo [2, 3-b] pyridine-3-carbonyl] -2, 4-difluoro-pheny l } -amide compositions and uses thereof.
JP2013510166A (en) 2009-11-06 2013-03-21 プレキシコン インコーポレーテッド Compounds, methods and applications for kinase regulation
TWI619713B (en) 2010-04-21 2018-04-01 普雷辛肯公司 Compounds and methods for kinase modulation, and indications therefor
PL2672967T3 (en) 2011-02-07 2019-04-30 Plexxikon Inc Compounds and methods for kinase modulation, and indications therefor
TW201348231A (en) * 2012-02-29 2013-12-01 Amgen Inc Heterobicyclic compounds
US9150570B2 (en) 2012-05-31 2015-10-06 Plexxikon Inc. Synthesis of heterocyclic compounds
KR20150082613A (en) * 2012-11-16 2015-07-15 머크 샤프 앤드 돔 코포레이션 Purine inhibitors of human phosphatidylinositol 3-kinase delta
CA2934700A1 (en) * 2014-01-06 2015-07-09 Rhizen Pharmaceuticals Sa Glutaminase inhibitors
CN106674132B (en) * 2016-11-22 2019-04-26 上海书亚医药科技有限公司 A kind of preparation method and application of miazines herbicide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4994456A (en) * 1989-03-01 1991-02-19 Nisshin Flour Milling Co., Ltd. Pyridinecarboxylic acid amide derivatives and pharmaceutical compositions comprising same
GB9514160D0 (en) * 1994-07-25 1995-09-13 Zeneca Ltd Aromatic compounds
FR2802533B1 (en) * 1999-12-17 2002-02-15 Sanofi Synthelabo PHENOXYPROPANOLAMINES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION
OA12292A (en) * 2000-06-26 2003-11-11 Pfizer Prod Inc PyrroloÄ2,3-dÜpyrimidine compounds as immunosuppressive agents.

Also Published As

Publication number Publication date
WO2004074278A1 (en) 2004-09-02

Similar Documents

Publication Publication Date Title
SE0300456D0 (en) Novel compounds
ATE452129T1 (en) N-PHENYL-2-PYRIMIDINE-AMINE DERIVATIVES
NO20070224L (en) 2-urea-4-phenylthiazole derivatives, preparation and therapeutic use thereof
BR0316350A (en) Diaminotriazoles useful as protein kinase inhibitors
MY139302A (en) Novel heterocyclic fluoroglycoside derivatives, medicaments containing these compounds, and the use thereof
SE0301700D0 (en) Novel compounds
SE0101387D0 (en) Novel compounds
ATE335748T1 (en) THIENOPYRIMIDIINDIONES AND THEIR USE IN MODULATING AUTOIMMUNE DISEASES
ATE512147T1 (en) MACROCYCLIC AMINIOPYRIDYL BETA SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE
DE502005008971D1 (en) SUBSTITUTED 1,4,8-TRIAZASPIROÄ4.5 DECAN-2-ON COMPOUNDS FOR THE TREATMENT OF FAT
EA200701930A1 (en) Derivatives of pyrimidine for the treatment of hyperproliferative disorders
EA200601212A1 (en) PHOSPHODESTERASE INHIBITORS, OBTAINING AND THEIR THERAPEUTIC APPLICATION
ATE524181T1 (en) USE OF 1,4-BIS(3-AMINOALKYL) PIPERAZINE DERIVATIVES IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
CO5660287A2 (en) DERIVATIVES OF TETRAHYDROCARBAZOL AND ITS PHARMACEUTICAL USE
SE0302139D0 (en) Novel compounds
EA200700400A1 (en) DERIVATIVES N- (1H-INDOLIL) -1H-INDOL-2-CARBOXAMIDES, THEIR PRODUCTION AND THEIR APPLICATION IN THERAPY
CY1109366T1 (en) Substituted Compounds 1,4,8-Triazazepiro [4.5] Decan-2-One
ATE482955T1 (en) AZABICYCLOOCTAN-3 DERIVATIVES AND THEIR USE
SE0300091D0 (en) Novel compounds
EA200401319A1 (en) NEW HETEROCYCLIC COMPOUNDS, METHODS FOR THEIR PRODUCTION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THESE COMPOUNDS AND THEIR USE IN MEDICINE
ATE482933T1 (en) SULFOPYRROL DERIVATIVES
ATE523199T1 (en) PYRIDAZINE COMPOUNDS AND METHODS
EA200600992A1 (en) AMIDA TIAZOLIDINONA, AMIDA THIAZOLIDINCARBONIC ACID, METHODS FOR THEIR RECEPTION AND THEIR APPLICATION
SE0303280D0 (en) Novel compounds
ATE432936T1 (en) IMIDAZOTRIAZINE COMPOUNDS USED TO TREAT CANCER DISEASES